| Literature DB >> 35807266 |
Lien T M Do1, Jirapast Sichaem2.
Abstract
Three new flavonoid derivatives, melodorones A-C (1-3), together with four known compounds, tectochrysin (4), chrysin (5), onysilin (6), and pinocembrin (7), were isolated from the stem bark of Melodorum fruticosum. Their structures were determined on the basis of extensive spectroscopic methods, including NMR and HRESIMS, and by comparison with the literature. Compounds 1-7 were evaluated for their in vitro α-glucosidase inhibition and cytotoxicity against KB, Hep G2, and MCF7 cell lines. Among them, compound 1 exhibited the best activity against α-glucosidase and was superior to the positive control with an IC50 value of 2.59 μM. On the other hand, compound 1 showed moderate cytotoxicity toward KB, Hep G2, and MCF7 cell lines with the IC50 values of 23.5, 19.8, and 23.7 μM, respectively. These findings provided new evidence that the stem bark of M. fruticosum is a source of bioactive flavonoid derivatives that are highly valuable for medicinal development.Entities:
Keywords: Annonaceae; Melodorum fruticosum; cytotoxicity; flavonoids; melodorones A–C; α-glucosidase inhibition
Mesh:
Substances:
Year: 2022 PMID: 35807266 PMCID: PMC9268484 DOI: 10.3390/molecules27134023
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Chemical structures of 1–7.
1H and 13C NMR spectroscopic data of 1–3 recorded in DMSO-d6 (δ in ppm).
| Position | 1 a | 2 b | 3 a | |||
|---|---|---|---|---|---|---|
| δH ( | δC | δH ( | δC | δH ( | δC | |
| 2 | 163.4 | 5.62, dd (12.6, 3.0) | 78.7 | 5.55, dd (13.0, 3.0) | 78.4 | |
| 3ax | 7.03, s | 104.9 | 3.31, dd (17.4, 13.2) | 42.2 | 3.31, overlapped | 42.8 |
| 3eq | 2.82, dd (16.8, 3.0) | 2.83, dd (17.0, 3.0) | ||||
| 4 | 182.4 | 197.1 | 198.7 | |||
| 5 | 152.8 | 154.4 | 148.3 | |||
| 6 | 130.6 | 128.3 | 136.1 | |||
| 7 | 159.3 | 161.1 | 139.5 | |||
| 8 | 6.97, s | 91.6 | 6.30, s | 92.0 | 6.27, s | 106.4 |
| 9 | 152.3 | 158.3 | 153.0 | |||
| 10 | 105.3 | 102.5 | 106.2 | |||
| 1′ | 130.6 | 138.5 | 138.8 | |||
| 2′ | 8.11, dd (7.0, 1.5) | 126.4 | 7.54, d (7.2) | 126.6 | 7.53, dd (8.5, 1.5) | 126.5 |
| 3′ | 7.58–7.63, m | 129.1 | 7.44, dd (7.2, 7.2) | 128.5 | 7.37–7.44, m | 128.5 |
| 4′ | 132.1 | 7.40, m | 128.6 | 128.4 | ||
| 5′ | 129.1 | 7.44, dd (7.2, 7.2) | 128.5 | 128.5 | ||
| 6′ | 8.11, dd (7.0, 1.5) | 126.4 | 7.54, d (7.2) | 126.6 | 7.53, dd (8.5, 1.5) | 126.5 |
| 1″ | 4.46, d (7.5) | 68.3 | 4.35, d (7.2) | 68.4 | 3.26, overlapped | 28.7 |
| 2″ | 5.45, m | 120.5 | 5.42, m | 120.6 | 5.24, m | 121.1 |
| 3″ | 137.4 | 137.1 | 132.7 | |||
| 4″ | 1.71, s | 25.4 | 1.70, s | 25.4 | 1.69, s | 25.4 |
| 5″ | 1.63, s | 17.7 | 1.61, s | 17.7 | 1.65, s | 17.6 |
| 5-OH | 12.77, s | 11.94, s | 11.71, s | |||
| 6-OH | 8.51, s | |||||
| 7-OCH3 | 3.94, s | 56.5 | 3.83, s | 56.3 | ||
a NMR at 500/125 MHz. b NMR at 600/125 MHz.
Figure 2Key HMBC correlations of 1–3.
α-Glucosidase inhibition (IC50 ± SD) of 1–7.
| Compound | IC50 (μM) |
|---|---|
|
| 2.59 ± 0.15 |
|
| 3.33 ± 0.28 |
|
| 4.00 ± 0.20 |
|
| >256 |
|
| 3.67 ± 0.25 |
|
| 192 ± 8.78 |
|
| >256 |
| Acarbose | 179 ± 6.02 |
Cytotoxicity of 1–7 against three human cancer cell lines.
| Compound | IC50 ± SD (µM) a | ||
|---|---|---|---|
| KB | Hep G2 | MCF7 | |
|
| 23.5 ± 1.1 | 19.8 ± 1.5 | 23.7 ± 2.0 |
|
| 62.1 ± 4.5 | 44.8 ± 4.0 | 73.7 ± 2.8 |
|
| 59.0 ± 2.5 | 80.0 ± 3.0 | >100 |
|
| 64.7 ± 3.0 | 68.0 ± 2.5 | 80.9 ± 7.4 |
|
| 32.0 ± 0.0 | 71.4 ± 3.9 | 80.0 ± 4.5 |
|
| >100 | >100 | >100 |
|
| >100 | >100 | >100 |
| Ellipticine b | 0.31 ± 0.05 | 0.33 ± 0.05 | 0.40 ± 0.05 |
a Results are expressed as the means ± SD of three replicates. b Ellipticine was used as the positive control. Human epidermoid carcinoma (KB), human hepatocellular carcinoma (Hep G2), and human breast adenocarcinoma (MCF-7).